Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares in GlaxoSmithKline plc purchased at a price of £12.77 per share on 15 October 2009, and Ordinary share ADRs in GlaxoSmithKline plc purchased at a price of $39.62 per ADR on 15 October 2009, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 8 October 2009.
|
Ordinary shares |
ADRs |
Mr A P Witty |
229.07 |
|
Mr J S Heslop |
0.01 |
|
Dr M M Slaoui |
133.56 |
|
Mrs C E Bruck Slaoui |
39.64 |
|
Mr S M Bicknell |
71.17 |
|
Mr J M Clarke |
139.34 |
|
Mr M Dunoyer |
86.27 |
|
Mr E J Gray |
152.25 |
|
Mr D Learmouth |
41.34 |
|
Mr W C Louv |
|
49.59 |
Mr D J Phelan |
|
136.73 |
Dr D Pulman |
|
79.09 |
Mr D S Redfern |
66.05 |
|
Ms C Thomas |
50.17 |
|
Mr J R Stéphenne |
435.92 |
|
The Company was advised of this information on 19 October 2009.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
20 October 2009